\BOOKMARK [1][-]{section.1}{Summary}{}% 1
\BOOKMARK [1][-]{section.2}{Specific Aims}{}% 2
\BOOKMARK [1][-]{section.3}{Background and Significance}{}% 3
\BOOKMARK [2][-]{subsection.3.1}{Significance}{section.3}% 4
\BOOKMARK [2][-]{subsection.3.2}{Caenorhabditis elegans as a model}{section.3}% 5
\BOOKMARK [2][-]{subsection.3.3}{Quantitative genetics in Caenorhabditis elegans}{section.3}% 6
\BOOKMARK [2][-]{subsection.3.4}{Identifying genetic determinants that contribute to phenotypic variation}{section.3}% 7
\BOOKMARK [2][-]{subsection.3.5}{Cellular function of topoisomerases}{section.3}% 8
\BOOKMARK [2][-]{subsection.3.6}{Type I topoisomerases}{section.3}% 9
\BOOKMARK [2][-]{subsection.3.7}{Type II topoisomerases}{section.3}% 10
\BOOKMARK [2][-]{subsection.3.8}{Topoisomerase II poisons - Etoposide, Amsacrine, and Mitoxantrone}{section.3}% 11
\BOOKMARK [2][-]{subsection.3.9}{Variation in response to topoisomerase II poisons in C.elegans}{section.3}% 12
\BOOKMARK [1][-]{section.4}{Experimental Design and Methods}{}% 13
\BOOKMARK [2][-]{subsection.4.1}{Specific Aim 1}{section.4}% 14
\BOOKMARK [3][-]{subsubsection.4.1.1}{Generate NILs to narrow confidence intervals}{subsection.4.1}% 15
\BOOKMARK [3][-]{subsubsection.4.1.2}{Establishing gene causality}{subsection.4.1}% 16
\BOOKMARK [3][-]{subsubsection.4.1.3}{Identifying causal genetic variant}{subsection.4.1}% 17
\BOOKMARK [1][-]{section.5}{Appendix}{}% 18
